Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MLNR | O43193 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.35 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.35 |
| ▸ | PLAAT3 | P53816 | 2/20 | 0.34 |
| ▸ | PLAAT5 | Q96KN8 | 2/20 | 0.34 |
| ▸ | PLAAT2 | Q9NWW9 | 2/20 | 0.34 |
| ▸ | PLAAT4 | Q9UL19 | 2/20 | 0.34 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.34 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.33 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.33 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5408657 | 0.85 | RAB9A (0.42) | TDP1MLNRKMT2ALPAR1HDAC1 | |
| SCHEMBL5394539 | 0.84 | POLB (0.40) | TDP1L3MBTL1ALDH1A1HCRTR1HCRTR2 | |
| SCHEMBL5409607 | 0.82 | ALDH1A1 (0.43) | ALDH1A1KMT2AHDAC1HDAC6 | |
| SCHEMBL5395306 | 0.82 | CDK4 (0.47) | ALDH1A1 | |
| SCHEMBL5409762 | 0.81 | MEN1 (0.37) | KMT2ALPAR1 | |
| SCHEMBL5398801 | 0.81 | KMT2A (0.54) | TDP1L3MBTL1ALDH1A1KMT2ALPAR1 | |
| SCHEMBL5414051 | 0.80 | KMT2A (0.46) | TDP1L3MBTL1MLNRCYP3A4FFAR1 | |
| SCHEMBL5399037 | 0.80 | TRPM8 (0.39) | TDP1L3MBTL1MLNRCYP3A4FFAR1 | |
| SCHEMBL5406363 | 0.80 | LTB4R (0.37) | TDP1L3MBTL1MLNRCYP3A4FFAR1 | |
| SCHEMBL5400596 | 0.79 | TRPV1 (0.48) | FFAR1ALDH1A1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7285680-B2 | β-alanine derivatives and the use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-10-23 | — | — | US | disclosed |
| US-20050256160-A1 | Beta-alanine derivatives and the use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2005-11-17 | — | — | US | disclosed |
| EP-1533294-A1 | BETA-ALANINE DERIVATIVE AND USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2005-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256160-A1 | Beta-alanine derivatives and the use thereof | TGFB1, PML, APOB | TDP1 1939/4885L3MBTL1 1016/4885MLNR 963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.